Publication Name	World Journal of Clinical Cases
Manuscript ID	77654
Country	China

Received	2022-05-13 13:53
Peer-Review Started	2022-05-13 13:55
To Make the First Decision
Return for Revision	2022-08-04 00:48
Revised	2022-08-09 15:14
Second Decision	2022-10-08 04:05
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-10-09 00:22
Articles in Press	2022-10-09 00:22
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-09-19 22:13
Typeset the Manuscript	2022-10-12 02:11
Publish the Manuscript Online	2022-10-27 04:55

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Case Report
Article Title	Tolvaptan ameliorated kidney function for one elderly autosomal dominant polycystic kidney disease patient: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Li Zhou, Yan Tian, Liang Ma and Wen-Ge Li
ORCID	Author(s) ORCID Number Li Zhou http://orcid.org/0000-0003-2880-488X
Funding Agency and Grant Number
Corresponding Author	Wen-Ge Li, MD, Director, Director, Department of Nephrology, China-Japan Friendship Hospital, No. 2 East Yinghuayuan Street, Chaoyang District, Beijing 100029, China. wenge_lee2002@126.com
Key Words	Chronic kidney disease; Autosomal dominant polycystic kidney disease; Deep vein thrombosis; Tolvaptan; Case report
Core Tip	Autosomal dominant polycystic kidney disease is a genetic and heritable kidney disease. It appears with cyst formation and growth, kidney enlargement and eventually leads to end stage renal disease. Some patients with severe polycystic kidney disease and end stage kidney disease have been treated with nephrectomy and early dialysis therapy, however, the life quality of these autosomal dominant polycystic kidney disease (ADPKD) patients declines due to the above treatment. In this case report, tolvaptan combined with edoxaban administration improved kidney function for one elderly ADPKD patient while avoiding the decreased life quality from nephrectomy or dialysis therapy.
Publish Date	2022-10-27 04:55
Citation	Zhou L, Tian Y, Ma L, Li WG. Tolvaptan ameliorated kidney function for one elderly autosomal dominant polycystic kidney disease patient: A case report. World J Clin Cases 2022; 10(31): 11500-11507
URL	https://www.wjgnet.com/2307-8960/full/v10/i31/11500.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i31.11500

Full Article (PDF)	WJCC-10-11500.pdf
Full Article (Word)	WJCC-10-11500.docx
CARE Checklist–2016	77654-CARE-Checklist–2016-revision.pdf
Manuscript File	77654_Auto_Edited-YJM-Filipodia CL-JLW.docx
Answering Reviewers	77654-Answering reviewers.pdf
Audio Core Tip	77654-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	77654-Conflict-of-interest statement.pdf
Copyright License Agreement	77654-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	77654-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	77654-Language certificate.pdf
Peer-review Report	77654-Peer-review(s).pdf
Scientific Misconduct Check	77654-Bing-Ma YJ-2.png
Scientific Editor Work List	77654-Scientific editor work list.pdf
CrossCheck Report	77654-CrossCheck report.pdf